[HTML][HTML] COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases

L Özbek, U Topçu, M Manay, BH Esen… - Clinical Microbiology …, 2023 - Elsevier
Background Mucormycosis, a rare fungal infection, has shown an increase in the number of
reported cases during the COVID-19 pandemic. Objectives To provide a comprehensive …

A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)

S Feys, MP Almyroudi, R Braspenning, K Lagrou… - Journal of Fungi, 2021 - mdpi.com
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

Invasive fusariosis

M Nucci, E Anaissie - Clinical Microbiology Reviews, 2023 - Am Soc Microbiol
Invasive fusariosis is a serious invasive fungal disease, affecting immunocompetent and,
more frequently, immunocompromised patients. Localized disease is the typical clinical form …

ICU-acquired infections in immunocompromised patients

L Kreitmann, J Helms, I Martin-Loeches, J Salluh… - Intensive Care …, 2024 - Springer
Immunocompromised patients account for an increasing proportion of the typical intensive
care unit (ICU) case-mix. Because of the increased availability of new drugs for cancer and …

Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India

V Muthu, R Agarwal, SM Rudramurthy… - Clinical Microbiology …, 2024 - Elsevier
Objectives To compare COVID-19-associated pulmonary mucormycosis (CAPM) with
COVID-19-associated rhino-orbital mucormycosis (CAROM), ascertain factors associated …

[HTML][HTML] Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy

R van Grootveld, MT van der Beek, NAF Janssen… - Journal of Critical …, 2023 - Elsevier
Purpose COVID-19 associated pulmonary aspergillosis (CAPA) is associated with increased
morbidity and mortality in ICU patients. We investigated the incidence of, risk factors for and …

Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19

LS Boers, F van Someren Gréve, JM van Hattem… - Intensive Care …, 2024 - Springer
Purpose Human herpesviruses, particularly cytomegalovirus (CMV) and herpes simplex
virus (HSV), frequently reactivate in critically ill patients, including those with acute …

Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital

V Avkan-Oğuz, M Celik, OÖ Eren-Kutsoylu… - … Medicine and Research, 2022 - Elsevier
Purpose To evaluate the management of patients with COVID-19 in the intensive care units
(ICUs) with fungal infection/colonization and to highlight diagnostic problems in these …

Herpes simplex virus and cytomegalovirus lung reactivations in severe COVID-19 patients: to treat or not to treat? That is (still) the question

CE Luyt, M Girardis, P Paixão - Intensive Care Medicine, 2024 - Springer
Patients developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection requiring mechanical ventilation (MV) are prone to develop nosocomial infections …

In vitro activity of amphotericin B in combination with colistin against fungi responsible for invasive infections

P Schwarz, I Nikolskiy, AL Bidaud, F Sommer, G Bange… - Journal of Fungi, 2022 - mdpi.com
The in vitro interaction of amphotericin B in combination with colistin was evaluated against
a total of 86 strains comprising of 47 Candida species (10 Candida albicans, 15 Candida …